Cascade Wealth Advisors, Inc Vaxart, Inc. Put Options Transaction History
Cascade Wealth Advisors, Inc
- $177 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VXRT
# of Institutions
97Shares Held
23MCall Options Held
66.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$837,4930.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$638,7640.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$634,9970.0% of portfolio
-
State Street Corp Boston, MA851KShares$306,4020.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $45.5M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...